Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19

Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autor principal: Samet, Jonathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953960/
https://www.ncbi.nlm.nih.gov/pubmed/33320258
http://dx.doi.org/10.1093/ntr/ntaa187
_version_ 1783664010806165504
author Samet, Jonathan M
author_facet Samet, Jonathan M
author_sort Samet, Jonathan M
collection PubMed
description Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infection and the course of COVID-19 is addressed.
format Online
Article
Text
id pubmed-7953960
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-79539602021-03-15 Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19 Samet, Jonathan M Nicotine Tob Res Commentaries Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infection and the course of COVID-19 is addressed. Oxford University Press 2020-12-15 /pmc/articles/PMC7953960/ /pubmed/33320258 http://dx.doi.org/10.1093/ntr/ntaa187 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Commentaries
Samet, Jonathan M
Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title_full Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title_fullStr Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title_full_unstemmed Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title_short Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
title_sort tobacco products and the risks of sars-cov-2 infection and covid-19
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953960/
https://www.ncbi.nlm.nih.gov/pubmed/33320258
http://dx.doi.org/10.1093/ntr/ntaa187
work_keys_str_mv AT sametjonathanm tobaccoproductsandtherisksofsarscov2infectionandcovid19

Ejemplares similares